The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy
- PMID: 17320337
- DOI: 10.1016/j.pec.2006.11.005
The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy
Abstract
Objective: The possible association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life has been studied in high-risk breast cancer survivors 5 years following standard adjuvant (n=23) versus high-dose chemotherapy (n=24) and in early-stage breast cancer patients (n=29) (comparison group) following radiation therapy.
Methods: A neuropsychological assessment covering attention, memory and executive functions was used together with the questionnaire for self-perceived deficits in attention (FEDA), the multidimensional fatigue inventory (MFI-20) and the EORTC-QLQ-C30.
Results: Findings have shown that neuropsychological impairment is not directly associated with self-perceived cognitive deficits, fatigue and HRQOL. However, 46% of patients reported self-perceived cognitive deficits and 82% of the patients complained about cancer related fatigue. Except for reduced activity we did not find significant group differences, even though patients who received standard-dose chemotherapy had consistently higher levels of self-perceived cognitive deficits and fatigue, and the lowest HRQOL.
Conclusion: Results emphasize the need for psychosocial counseling and support during treatment phase and follow up care as well. Sensitive cancer-specific measures for the assessment of self-perceived cognitive deficits in different cognitive domains according to neuropsychological measurements are required.
Practice implications: The role of self-perceived cognitive deficits and fatigue should be considered in educational interventions and counseling. Specific rehabilitation measures should be developed, implemented and evaluated in order to meet the needs of these patients and to decrease the frequency of cognitive deficits following cancer treatment.
Similar articles
-
Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.J Clin Oncol. 2003 Nov 15;21(22):4175-83. doi: 10.1200/JCO.2003.01.119. J Clin Oncol. 2003. PMID: 14615445
-
Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors.J Clin Nurs. 2005 Feb;14(2):204-11. doi: 10.1111/j.1365-2702.2004.01030.x. J Clin Nurs. 2005. PMID: 15669929
-
Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.J Clin Oncol. 2005 Nov 1;23(31):8025-32. doi: 10.1200/JCO.2005.01.6550. J Clin Oncol. 2005. PMID: 16258100 Clinical Trial.
-
The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.Brain Cogn. 2005 Oct;59(1):60-70. doi: 10.1016/j.bandc.2005.05.001. Epub 2005 Jun 21. Brain Cogn. 2005. PMID: 15975700 Review.
-
Quality of life in breast cancer.Cancer Pract. 1996 Nov-Dec;4(6):331-40. Cancer Pract. 1996. PMID: 9128486 Review.
Cited by
-
High-dose chemotherapy with hematopoietic stem cell transplantation for the treatment of primary central nervous system lymphoma.J Neurooncol. 2011 Feb;101(3):345-55. doi: 10.1007/s11060-010-0279-5. Epub 2010 Jul 4. J Neurooncol. 2011. PMID: 20607357 Review.
-
Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study.BMC Cancer. 2014 Mar 24;14:219. doi: 10.1186/1471-2407-14-219. BMC Cancer. 2014. PMID: 24661373 Free PMC article. Clinical Trial.
-
The effect of cigarette smoking on cancer treatment-related side effects.Oncologist. 2011;16(12):1784-92. doi: 10.1634/theoncologist.2011-0169. Epub 2011 Dec 1. Oncologist. 2011. PMID: 22135122 Free PMC article.
-
Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: a systematic review and meta-analysis.Sci Rep. 2022 Feb 8;12(1):2135. doi: 10.1038/s41598-022-05682-1. Sci Rep. 2022. PMID: 35136066 Free PMC article.
-
Subjective cognitive functioning and associations with psychological distress in adult brain tumour survivors.J Cancer Surviv. 2019 Oct;13(5):653-662. doi: 10.1007/s11764-019-00784-8. Epub 2019 Jul 17. J Cancer Surviv. 2019. PMID: 31313128
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical